Physician profile
William Horton
NPI 1811071525
$2,923.27
in general payments reported to CMS, 2019-2025
26 companies · $382 in 2025
The $382 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2020: $59.07 · 2021: $316 · 2022: $417 · 2023: $631 · 2024: $827 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,806 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,805.72 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $617.39 | 2021-2025 | |
| Optinose US, INC. | $516.40 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $507.66 | 2021-2024 | Dupixent |
| Glaxosmithkline, LLC. | $371.95 | 2021-2025 | Nucala |
| Acclarent, INC | $211.62 | 2019-2024 | Relieva Spinplus, Trudi Nav Cable, Acclarent Navwire |
| Aerin Medical INC. | $163.14 | 2019-2024 | |
| Baxter Healthcare | $72.76 | 2023-2025 | Perclot, Tisseel |
| Stryker Corporation | $57.82 | 2022-2024 | Clarifix Cryotherapy Device |
| Boston Scientific Corporation | $53.88 | 2025 | Apollo Esg Nxt System |
| Inspire Medical Systems, INC. | $42.28 | 2023-2024 | Inspire |
| Amgen INC. | $34.00 | 2025 | |
| Shire North American Group INC | $32.74 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $24.96 | 2025 | Neffy |
| Medtronic, INC. | $21.63 | 2024 | Bizact |
| Hologic Sales and Service, LLC | $20.72 | 2023 | Coolseal Generator |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $19.60 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $19.32 | 2025 | Tezspire |
| Smith+Nephew, INC. | $19.17 | 2024 | Ent Sinus, Rf20000, Halo |
| Sanara Medtech INC. | $18.58 | 2023 | Celleraterx |
| Genentech USA, INC. | $16.39 | 2019 | |
| Merck Sharp & Dohme LLC | $15.34 | 2023 | |
| Novartis Pharmaceuticals Corporation | $14.70 | 2019 | |
| Phadia US INC. | $13.82 | 2019 | |
| Hikma Pharmaceuticals USA | $13.66 | 2024 | Ryaltris |
| Covidien Lp | $12.80 | 2019 | |
| Olympus America INC. | $10.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Horton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.